UK pharma major GSK today announced positive pivotal data for bepirovirsen, its investigational antisense oligonucleotide (ASO) for the treatment of chronic hepatitis B (CHB).

Recipharm, a Swedish global contract development and manufacturing organization (CDMO), today announced a multi-million investment in a new Blow-Fill-Seal (BFS) manufacturing line, expanding capacity ...

US pharma major Eli Lilly today announced an access milestone in obesity care: all three of the nation's largest pharmacy benefit managers (PBMs) will cover Lilly's full obesity medicine portfolio.

GSK today announced that NICE has issued draft final guidance recommending Nucala (mepolizumab) for use on the National Health Service (NHS), as an add-on maintenance treatment option for adult ...

Rhapsido (remibrutinib) is approved to treat chronic spontaneous urticaria (CSU). CSU affects the skin and is thought to be an autoimmune disease (when the immune system mistakenly attacks the body’s ...

The US Food and Drug Administration (FDA) has granted priority review to the new drug application (NDA) for Sanofi’s (Euronext: SAN) venglustat, a novel, investigational oral glucosylceramide synthase ...

US clinical-stage biotech Apogee Therapeutics today announced that it has entered into a strategic financing collaboration ...

US pharma major Eli Lilly, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive top-line ...

New US subgroup data for German pharma major Boehringer Ingelheim’s Jascayd (nerandomilast) in idiopathic and progressive ...

Privately-held UK based AMR Bio has announced its launch as a clinical phase biotechnology company focused on one of the most ...

Infex Therapeutics, a UK anti-infectives specialist, today announced positive results from its Phase IIa dose-ranging study ...

US biotech Biogen (Nasdaq: BIIB) and Denali Therapeutics (Nasdaq: DNLI) are discontinuing development of Parkinson’s disease ...